Legal status · United States
Is Sermorelin with ipamorelin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Sermorelin with ipamorelin is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Sermorelin with ipamorelin in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy. |
| FDA approval status | Not approved as a combination. Sermorelin held US approval and was withdrawn from the market for commercial reasons; ipamorelin has never been approved anywhere. |
| Human studies cited | 3 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Sermorelin with ipamorelin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Sermorelin with ipamorelin is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Sermorelin with ipamorelin is
The combination most likely to arrive from a compounding pharmacy with a prescriber's name on it, usually as a nightly subcutaneous dose. The combination has never been tested. Sermorelin was an approved medicine and the ipamorelin half has one randomised human trial, in 117 post-surgical patients, where it was safe and did not beat placebo on its endpoint.
This is the respectable end of the blend market: a prescriber, a compounding pharmacy, a labelled syringe, an instruction to inject at bedtime five nights a week. That framing carries an implication that something was evaluated.
Mechanism: Sermorelin binds the GHRH receptor on pituitary somatotrophs and increases the amplitude of a growth hormone pulse. Ipamorelin binds the growth hormone secretagogue receptor and triggers a pulse, selected by prescribers for releasing growth hormone with less effect on cortisol and prolactin than the older GHRPs.
Regulatory history: Not approved as a combination. Sermorelin held US approval and was withdrawn from the market for commercial reasons; ipamorelin has never been approved anywhere.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Sermorelin with ipamorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sermorelin with ipamorelin in other countries
Frequently asked questions
Is Sermorelin with ipamorelin legal in the United States?
No. Sermorelin with ipamorelin is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy.
Can I buy Sermorelin with ipamorelin in the United States?
No approved product exists to buy. In the United States Sermorelin with ipamorelin is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy.
Is Sermorelin with ipamorelin FDA approved?
No. FDA status: Not approved as a combination. Sermorelin held US approval and was withdrawn from the market for commercial reasons; ipamorelin has never been approved anywhere.. Current US classification: "Not approved; research use only". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sermorelin with ipamorelin live on its compound profile.
Sermorelin with ipamorelin profileThis page is general information about the regulatory status of Sermorelin with ipamorelin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.